Stemgenics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series B2

  • Latest Deal Amount
  • $445K

  • Investors
  • 1

Stemgenics General Information

Description

Operator of a biotechnology company intended for skin treatment. The company's nanotherapeutics platform offers the regeneration of a variety of tissues of the human body to convert mature cells into personalized stem cells, reprogramming adult human cells into other pre-determined specialized cell types, enabling scientists to reset the biological clock of the cell and renewing the life cycle of the patient's skin.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Corporate Office
  • 454 North 34th Street
  • Suite 100
  • Seattle, WA 98103
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stemgenics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B2) 12-Jul-2018 $445K 00.000 000.00 Completed Generating Revenue
3. Seed Round 29-Dec-2015 00.00 00.00 000.00 Completed Startup
2. Seed Round 03-Jan-2014 $1.1M $1.1M Completed Generating Revenue
1. Grant 28-Jun-2012 $150K Completed Startup
To view Stemgenics’s complete valuation and funding history, request access »

Stemgenics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2a 000,000 00.00 00.00 00 00.00 0.000
Series B2d 0,000,000 00.00 00.00 00 00.00 00
Series B2c 0,000,000 00.00 00.00 00 00.00 00
Series B2b 000,000 00.00 00.00 00 00.00 00
Series B 000,000 00.00 00.00 00 00.00 0.000
Series A 2,566,655 $0.43 $0.43 1x $0.43 25.56%
Seed 2,310,000 $0.03 $0.03 1x $0.03 23%
To view Stemgenics’s complete cap table history, request access »

Stemgenics Patents

Stemgenics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230116019-A1 Nanoparticles for expression of genes of interest and/or regulation of signaling pathways Pending 10-Jan-2020 00000000000
EP-3525831-A1 Nanoparticles functionalized with gene editing tools and related methods Pending 11-Oct-2016 0000000000
CA-3039924-A1 Nanoparticles functionalized with gene editing tools and related methods Pending 11-Oct-2016 0000000000
US-20190233820-A1 Nanoparticles functionalized with gene editing tools and related methods Pending 11-Oct-2016 0000000000 0
EP-3525831-A4 Nanoparticles functionalized with gene editing tools and related methods Pending 11-Oct-2016 C12N15/113 0
To view Stemgenics’s complete patent history, request access »

Stemgenics Executive Team (3)

Name Title Board Seat Contact Info
Andranik Aprikyan Ph.D Co-Founder, Chief Scientific Officer & Chief Executive Officer
Mushegh Hovhannisyan Executive Officer and Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

Stemgenics Board Members (3)

Name Representing Role Since
Anush Oganesian Self Board Member 000 0000
Mushegh Hovhannisyan Stemgenics Executive Officer and Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Stemgenics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stemgenics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
To view Stemgenics’s complete investors history, request access »

Stemgenics FAQs

  • When was Stemgenics founded?

    Stemgenics was founded in 2008.

  • Who is the founder of Stemgenics?

    Andranik Aprikyan Ph.D is the founder of Stemgenics.

  • Who is the CEO of Stemgenics?

    Andranik Aprikyan Ph.D is the CEO of Stemgenics.

  • Where is Stemgenics headquartered?

    Stemgenics is headquartered in Seattle, WA.

  • What is the size of Stemgenics?

    Stemgenics has 3 total employees.

  • What industry is Stemgenics in?

    Stemgenics’s primary industry is Biotechnology.

  • Is Stemgenics a private or public company?

    Stemgenics is a Private company.

  • What is the current valuation of Stemgenics?

    The current valuation of Stemgenics is 000.00.

  • What is Stemgenics’s current revenue?

    The current revenue for Stemgenics is 000000.

  • How much funding has Stemgenics raised over time?

    Stemgenics has raised $3.35M.

  • Who are Stemgenics’s investors?

    National Science Foundation has invested in Stemgenics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »